Researchers discover potential new approach to treating psoriatic joint inflammation Experiences with peptides BPC 157 and TB 500? Signaling pathways and targeted therapies for psoriasis Signal Transduction and Targeted Therapy Many treatment guidelines for psoriasis rely heavily on body surface area (BSA) involvement to determine disease severity and eligibility for systemic therapies like biologics. Traditionally, patients with less than 10% BSA involvementespecially Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS Inflammatory memory in psoriasis: From remission to recurrence Journal of Allergy and Clinical Immunology